Seven decades of antipsychotic drugs: why is the life of Australians with schizophrenia still so suboptimal?

David Castle; David Copolov; Bruce Singh; Tarun Bastiampillai

doi:10.1177/00048674231209840

Seven decades of antipsychotic drugs: why is the life of Australians with schizophrenia still so suboptimal?

David Castle, David Copolov, Bruce Singh, Tarun Bastiampillai

Research output: Contribution to journal › Article › Other › peer-review

5 Citations (Scopus)

Abstract

The advent of dopamine (D2) receptor-blocking medications over 70 years ago, ushered in a new era of biological treatment for schizophrenia. However, we argue that little subsequent progress has been made in translating this into fulfilled and fulfilling lives for people with schizophrenia. This Viewpoint asks why this is the case, and suggests ways forward for capitalising on extant and emerging new treatments for psychotic disorders, to the betterment of the lives of people living with schizophrenia.

Original language	English
Pages (from-to)	201-206
Number of pages	6
Journal	Australian and New Zealand Journal of Psychiatry
Volume	58
Issue number	3
DOIs	https://doi.org/10.1177/00048674231209840
Publication status	Published - Mar 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

antipsychotics
healthcare systems
psychosocial care
Schizophrenia

Access to Document

10.1177/00048674231209840

Cite this

@article{5780b70bfe134a488015c675911811df,

title = "Seven decades of antipsychotic drugs: why is the life of Australians with schizophrenia still so suboptimal?",

abstract = "The advent of dopamine (D2) receptor-blocking medications over 70 years ago, ushered in a new era of biological treatment for schizophrenia. However, we argue that little subsequent progress has been made in translating this into fulfilled and fulfilling lives for people with schizophrenia. This Viewpoint asks why this is the case, and suggests ways forward for capitalising on extant and emerging new treatments for psychotic disorders, to the betterment of the lives of people living with schizophrenia.",

keywords = "antipsychotics, healthcare systems, psychosocial care, Schizophrenia",

author = "David Castle and David Copolov and Bruce Singh and Tarun Bastiampillai",

note = "Publisher Copyright: {\textcopyright} The Royal Australian and New Zealand College of Psychiatrists 2023.",

year = "2024",

month = mar,

doi = "10.1177/00048674231209840",

language = "English",

volume = "58",

pages = "201--206",

journal = "Australian and New Zealand Journal of Psychiatry",

issn = "0004-8674",

publisher = "SAGE Publications Ltd",

number = "3",

}

TY - JOUR

T1 - Seven decades of antipsychotic drugs

T2 - why is the life of Australians with schizophrenia still so suboptimal?

AU - Castle, David

AU - Copolov, David

AU - Singh, Bruce

AU - Bastiampillai, Tarun

N1 - Publisher Copyright: © The Royal Australian and New Zealand College of Psychiatrists 2023.

PY - 2024/3

Y1 - 2024/3

N2 - The advent of dopamine (D2) receptor-blocking medications over 70 years ago, ushered in a new era of biological treatment for schizophrenia. However, we argue that little subsequent progress has been made in translating this into fulfilled and fulfilling lives for people with schizophrenia. This Viewpoint asks why this is the case, and suggests ways forward for capitalising on extant and emerging new treatments for psychotic disorders, to the betterment of the lives of people living with schizophrenia.

AB - The advent of dopamine (D2) receptor-blocking medications over 70 years ago, ushered in a new era of biological treatment for schizophrenia. However, we argue that little subsequent progress has been made in translating this into fulfilled and fulfilling lives for people with schizophrenia. This Viewpoint asks why this is the case, and suggests ways forward for capitalising on extant and emerging new treatments for psychotic disorders, to the betterment of the lives of people living with schizophrenia.

KW - antipsychotics

KW - healthcare systems

KW - psychosocial care

KW - Schizophrenia

UR - https://www.scopus.com/pages/publications/85180495741

U2 - 10.1177/00048674231209840

DO - 10.1177/00048674231209840

M3 - Article

C2 - 38130026

AN - SCOPUS:85180495741

SN - 0004-8674

VL - 58

SP - 201

EP - 206

JO - Australian and New Zealand Journal of Psychiatry

JF - Australian and New Zealand Journal of Psychiatry

IS - 3

ER -

Seven decades of antipsychotic drugs: why is the life of Australians with schizophrenia still so suboptimal?

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Cite this